{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:02:38Z","timestamp":1780498958042,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1150-1","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T12:03:19Z","timestamp":1562587399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Analysis of the caregiver burden associated with Sanfilippo syndrome type B: panel recommendations based on qualitative and quantitative data"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0276-0276","authenticated-orcid":false,"given":"Elsa","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Marques","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan Onenli","family":"Mungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Muschol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Vijayaraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/ped.12636","volume":"57","author":"F Andrade","year":"2015","unstructured":"Andrade F, Aldamiz-Echevarria L, Llarena M, Couce ML. Sanfilippo syndrome: overall review. Pediatr Int. 2015;57:331\u20138.","journal-title":"Pediatr Int"},{"key":"1150_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/TACG.S57672","volume":"8","author":"AO Fedele","year":"2015","unstructured":"Fedele AO. Sanfilippo syndrome: causes, consequences, and treatments. Appl Clin Genet. 2015;8:269\u201381.","journal-title":"Appl Clin Genet"},{"key":"1150_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13023-017-0717-y","volume":"12","author":"C Lavery","year":"2017","unstructured":"Lavery C, Hendriksz CJ, Jones SA. Mortality in patients with Sanfilippo syndrome. Orphanet J Rare Dis. 2017;12:168.","journal-title":"Orphanet J Rare Dis"},{"key":"1150_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13023-016-0521-0","volume":"11","author":"S Somanadhan","year":"2016","unstructured":"Somanadhan S, Larkin PJ. Parents' experiences of living with, and caring for children, adolescents and young adults with mucopolysaccharidosis (MPS). Orphanet J Rare Dis. 2016;11:138.","journal-title":"Orphanet J Rare Dis."},{"key":"1150_CR5","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1007\/s10803-017-3262-6","volume":"47","author":"C Wolfenden","year":"2017","unstructured":"Wolfenden C, Wittkowski A, Hare DJ. Symptoms of autism spectrum disorder (ASD) in individuals with mucopolysaccharide disease type III (Sanfilippo syndrome): a systematic review. J Autism Dev Disord. 2017;47:3620\u201333.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"1150_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ajmg.a.33779","volume":"155","author":"B\u00e9n\u00e9dicte H\u00e9ron","year":"2010","unstructured":"Heron B, Mikaeloff Y, Froissart R, Caridade G, Maire I, Caillaud C, et al. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A. 2011, 155A:58\u201368.","journal-title":"American Journal of Medical Genetics Part A"},{"key":"1150_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","volume":"31","author":"MJ Valstar","year":"2008","unstructured":"Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA. Sanfilippo syndrome: a mini-review. J Inherit Metab Dis. 2008;31:240\u201352.","journal-title":"J Inherit Metab Dis"},{"key":"1150_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/apa.12169","volume":"102","author":"FA Wijburg","year":"2013","unstructured":"Wijburg FA, Wegrzyn G, Burton BK, Tylki-Szymanska A. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder. Acta Paediatr. 2013;102:462\u201370.","journal-title":"Acta Paediatr"},{"key":"1150_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/adc.2004.065482","volume":"90","author":"J Fraser","year":"2005","unstructured":"Fraser J, Gason AA, Wraith JE, Delatycki MB. Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study. Arch Dis Child. 2005;90:1239\u201342.","journal-title":"Arch Dis Child"},{"key":"1150_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10545-010-9199-y","volume":"33","author":"MJ Valstar","year":"2010","unstructured":"Valstar MJ, Bruggenwirth HT, Olmer R, Wevers RA, Verheijen FW, Poorthuis BJ, et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherit Metab Dis. 2010;33:759\u201367.","journal-title":"J Inherit Metab Dis"},{"key":"1150_CR11","doi-asserted-by":"crossref","unstructured":"Kuiper GA, Meijer OLM, Langereis EJ, Wijburg FA. Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications. Orphanet J Rare Dis. 2018;13(2).","DOI":"10.1186\/s13023-017-0733-y"},{"issue":"may08 1","key":"1150_CR12","doi-asserted-by":"publisher","first-page":"bcr2013009592","DOI":"10.1136\/bcr-2013-009592","volume":"2013","author":"J. Brady","year":"2013","unstructured":"Brady J, Trehan A, Landis D, Toro C. Mucopolysaccharidosis type IIIB (MPS IIIB) masquerading as a behavioural disorder. BMJ Case Rep. 2013; \n                    https:\/\/doi.org\/10.1136\/bcr-2013-009592\n                    \n                  . (e-publication ahead of print)","journal-title":"Case Reports"},{"key":"1150_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10545-013-9661-8","volume":"37","author":"D Buhrman","year":"2014","unstructured":"Buhrman D, Thakkar K, Poe M, Escolar ML. Natural history of Sanfilippo syndrome type a. J Inherit Metab Dis. 2014;37:431\u20137.","journal-title":"J Inherit Metab Dis"},{"key":"1150_CR14","first-page":"127","volume":"16","author":"S Deshpande","year":"2015","unstructured":"Deshpande S, Sathe KR. A child with advanced mucopolysaccharidosis presenting with severe behavioural problems. ASEAN J Psychiatry. 2015;16:127\u201330.","journal-title":"ASEAN J Psychiatry"},{"key":"1150_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymgmr.2016.01.003","volume":"6","author":"E Shapiro","year":"2016","unstructured":"Shapiro E, King K, Ahmed A, Rudser K, Rumsey R, Yund B, et al. The neurobehavioral phenotype in Mucopolysaccharidosis type IIIB: an exploratory study. Mol Genet Metab Rep. 2016;6:41\u20137.","journal-title":"Mol Genet Metab Rep"},{"issue":"suppl 1","key":"1150_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10198-016-0787-0","volume":"17","author":"M Pentek","year":"2016","unstructured":"Pentek M, Gulacsi L, Brodszky V, Baji P, Boncz I, Pogany G, et al. Social\/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe. Eur J Health Econ. 2016;17(suppl 1):89\u201398.","journal-title":"Eur J Health Econ"},{"key":"1150_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10545-012-9558-y","volume":"36","author":"S Grant","year":"2013","unstructured":"Grant S, Cross E, Wraith JE, Jones S, Mahon L, Lomax M, et al. Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID). J Inherit Metab Dis. 2013;36:281\u201391.","journal-title":"J Inherit Metab Dis"},{"key":"1150_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ymgme.2015.02.008","volume":"114","author":"EG Shapiro","year":"2015","unstructured":"Shapiro EG, Nestrasil I, Ahmed A, Wey A, Rudser KR, Delaney KA, et al. Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo behavior rating scale. Mol Genet Metab. 2015;114:594\u20138.","journal-title":"Mol Genet Metab"},{"key":"1150_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13023-016-0503-2","volume":"11","author":"CJ Hendriksz","year":"2016","unstructured":"Hendriksz CJ, Berger KI, Lampe C, Kircher SG, Orchard PJ, Southall R, et al. Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues. Orphanet J Rare Dis. 2016;11:119.","journal-title":"Orphanet J Rare Dis."},{"key":"1150_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10897-014-9791-7","volume":"24","author":"M Needham","year":"2015","unstructured":"Needham M, Packman W, Quinn N, Rappoport M, Aoki C, Bostrom A, et al. Health-related quality of life in patients with MPS II. J Genet Couns. 2015;24:635\u201344.","journal-title":"J Genet Couns"},{"key":"1150_CR21","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s11136-014-0703-y","volume":"23","author":"I Wiklund","year":"2014","unstructured":"Wiklund I, Raluy-Callado M, Chen WH, Muenzer J, Fang J, Whiteman D. The hunter syndrome-functional outcomes for clinical understanding scale (HS-FOCUS) questionnaire: item reduction and further validation. Qual Life Res. 2014;23:2457\u201362.","journal-title":"Qual Life Res"},{"key":"1150_CR22","unstructured":"Galen Research. Alzheimer's Carer's Quality of Life Instrument (ACQLI) [\n                    https:\/\/eprovide.mapi-trust.org\/instruments\/alzheimer-s-carer-s-quality-of-life-instrument\n                    \n                  ]. Accessed 28 June 2019."},{"key":"1150_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1477-7525-7-56","volume":"7","author":"BG Vickrey","year":"2009","unstructured":"Vickrey BG, Hays RD, Maines ML, Vassar SD, Fitten J, Strickland T. Development and preliminary evaluation of a quality of life measure targeted at dementia caregivers. Health Qual Life Outcomes. 2009;7:56.","journal-title":"Health Qual Life Outcomes"},{"key":"1150_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1399-0004.2007.00784.x","volume":"71","author":"A Aubeeluck","year":"2007","unstructured":"Aubeeluck A, Buchanan H. The Huntington's disease quality of life battery for carers: reliability and validity. Clin Genet. 2007;71:434\u201345.","journal-title":"Clin Genet"},{"key":"1150_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11136-012-0227-2","volume":"22","author":"A Aubeeluck","year":"2013","unstructured":"Aubeeluck A, Dorey J, Squitieri F, Clay E, Stupple EJ, De Nicola A, et al. Further evidence of reliability and validity of the Huntington's disease quality of life battery for carers: Italian and French translations. Qual Life Res. 2013;22:1093\u20138.","journal-title":"Qual Life Res"},{"key":"1150_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ejpn.2019.02.014","volume":"23","author":"A Strzelczyk","year":"2019","unstructured":"Strzelczyk A, Kalski M, Bast T, Wiemer-Kruel A, Bettendorf U, Kay L, et al. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: a prospective, multicenter study from Germany. Eur J Paediatr Neurol. 2019;23:392\u2013403.","journal-title":"Eur J Paediatr Neurol."},{"key":"1150_CR27","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/13696998.2018.1487447","volume":"21","author":"AM Skalicky","year":"2018","unstructured":"Skalicky AM, Rentz AM, Liu Z, Said Q, Nakagawa JA, Frost MD, et al. Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families. J Med Econ. 2018;21:953\u20139.","journal-title":"J Med Econ"},{"key":"1150_CR28","first-page":"808421","volume":"2014","author":"I Karakis","year":"2014","unstructured":"Karakis I, Cole AJ, Montouris GD, San Luciano M, Meador KJ, Piperidou C. Caregiver burden in epilepsy: determinants and impact. Epilepsy Res Treat. 2014;2014:808421.","journal-title":"Epilepsy Res Treat"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1150-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1150-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1150-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:21:19Z","timestamp":1594077679000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1150-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1150-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The secondary research is based on survey data and thus no ethics approval was required. The secondary research was based on survey data in which the participants agreed to answer. No formal consent was required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ES reports consulting fees from Shapiro Neuropsychology Consulting, LLC. CML has received honoraria for speakers\u2019 fees from Actelion, Genzyme, and Shire HGT; all fees are donated to the CML Medical Foundation for Research and Genetic Diagnosis Support for families with unknown genetic disorders. NM is a consultant for BioMarin, Shire, Genzyme Sanofi, Lysogene, and SOBI; has received grants\/research support from BioMarin, Shire, and Genzyme Sanofi; and has received honoraria and travel grants from BioMarin, Shire, Genzyme Sanofi, Actelion, and Amicus. CO\u2019N and NOM declare they have no competing interests. SV has received research support from Alexion Pharmaceuticals; has received travel grants from Actelion, BioMarin, Genzyme, and Shire; and has served as an advisory board member for Vtesse.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}